This parallel-group, double- blind, ransomised, placebo-controlled trial conducted in 26 United Kingdom centres, investigated the efficacy and tolerability of mirtazapine versus placebo in treating agitation in patients with probable or possible Alzheimer’s disease.

This study investigated the potential benefits of smoking cessation in slowing down clinical progression in patients with multiple sclerosis.

Twenty patients hospitalized with COVID-19 encephalopathy were included in this retrospective cohort study.

In this case-control study, the authors evaluated NSSS from a cohort of 7,812,845 BNT162b2 first-dose recipients, of whom 10,929 reported an adverse event following immunization.

This narrative review was conducted to collect and discuss published data about neurological side effects of SARS-CoV-2 vaccines in order to discover type, frequency, treatment, and outcome of these side effects.

The objective of this retrospective cross-sectional study was to generate real-world multiple sclerosis–specific vaccine safety information, particularly in the context of specific DMTs, and provide information to mitigate specific concerns in vaccine hesitant PwMS.

This single-center retrospective observational study compared stroke characteristics between patients with and without COVID-19.

In this article the author sought to highlight the most remarkable findings concerning headache secondary to COVID-19, specifically focusing on epidemiology, characteristics, pathophysiology, and treatments.

In this study the authors retrospectively studied 4742 patients with acute infectious respiratory disease (AIRD); 2579 were diagnosed to have COVID-19 and treated with heparin, whereas 2163 had other causes of AIRD.

In this article the authors used state-of-the-art multiplexed immunostaining of human brains and demonstrated that expression of the SARS-CoV-2 receptor ACE2 is restricted to a subset of neurovascular pericytes.

In this article the authors aimed to explore the interaction between COVID-19 and Alzheimer's disease by integrating bioinformatics to find the biomarkers which lead to AD occurrence and development with COVID-19 and provide early intervention.

In this article the authors aimed to explore the impact of the pandemic on community-dwelling individuals with mild-to-moderate dementia and compare responses with pre-pandemic data.

This work aimed at exploring how post-infective cognitive status relates to clinical/treatment outcomes by controlling for premorbid/current risk factors for cognitive deficits.

The purpose of this systematic review study was to investigate the epidemic effect of COVID-19 on increasing the prevalence of mental disorders such as depression, anxiety, and sleep disorders in people with epilepsy.

The aim of the study was to determine the association between previous stroke and mortality after coronavirus disease 2019 (COVID-19) according to sex, age groups, and stroke subtypes.